Cilengitide in Treating Patients With Metastatic Prostate Cancer

NCT00103337 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

106

Enrollment

NIH

Sponsor class

Conditions

Recurrent Prostate Cancer
Stage IV Prostate Cancer

Interventions

DRUG: cilengitide
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)